Skip to content

RCEL

AVITA Medical, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$11.20
+2.38%
Ask drillr
3
Insider buys (3m)
0
Insider sells (3m)
$49.7K
Net value (3m)
+165.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 24, 2026O'Toole David D · officer: CFOPurchase2,000$3.97
Jun 12, 2026O'Toole David D · officer: CFOA-Award2,000$3.97
Jun 10, 2026Woody Joseph Fralin · directorPurchase5,200$4.00
Jun 9, 2026Woody Joseph Fralin · directorPurchase5,000$4.20
Jun 5, 2026Woody Joseph Fralin · directorPurchase5,000$4.10
Jun 4, 2026Woody Joseph Fralin · directorA-Award29,446$3.47
Jun 4, 2026Woody Joseph Fralin · directorA-Award16,133$3.77
Jun 4, 2026Tarnoff Michael E · directorA-Award26,250$0.00
Jun 4, 2026Tarnoff Michael E · directorA-Award22,214$0.00
Jun 4, 2026Tarnoff Michael E · directorA-Award19,063$5.36
Jun 4, 2026Tarnoff Michael E · directorA-Award16,133$3.77
Jun 4, 2026COOK JEREMY CURNOCK · directorA-Award22,214$0.00
Jun 4, 2026COOK JEREMY CURNOCK · directorA-Award16,133$3.77
Jun 4, 2026Crowe Suzanne · directorA-Award22,214$0.00
Jun 4, 2026Crowe Suzanne · directorA-Award16,133$3.77
Jun 4, 2026REED JAN STERN · directorA-Award22,214$0.00
Jun 4, 2026REED JAN STERN · directorA-Award16,133$3.77
Jun 4, 2026McNamara Robert · directorA-Award16,133$3.77
Jun 4, 2026McNamara Robert · directorA-Award22,214$0.00
Jun 4, 2026Woody Joseph Fralin · directorA-Award40,547$0.00
Jun 4, 2026Woody Joseph Fralin · directorA-Award22,214$0.00
Jun 1, 2026O'Toole David D · officer: CFOA-Award5,000$3.05
Jun 1, 2026Vance Cary Guy · director, officer: President and CEOA-Award5,000$3.05
May 20, 2026O'Toole David D · officer: CFOPurchase2,000$4.26
May 19, 2026O'Toole David D · officer: CFOPurchase2,000$4.24
Mar 11, 2026O'Toole David D · officer: CFOPurchase1,800$4.78
Feb 23, 2026O'Toole David D · officer: CFOPurchase3,000$4.15
Feb 19, 2026O'Toole David D · officer: CFOA-Award155,510$4.31
Feb 19, 2026KELSEY NICOLE · officer: Chief Legal OfficerA-Award145,060$4.31
Feb 19, 2026O'Toole David D · officer: CFOA-Award105,470$0.00
Institutional positioning

13F filings over the trailing two quarters

New 28Increased 27Reduced 16Sold out 79
FilerActionSharesFiled
ORBIMED ADVISORS LLCNew Position82,010,995May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1,335,152May 15, 2026
BLACKROCK, INC.Increased1,133,126May 13, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased542,974May 15, 2026
STATE STREET CORPIncreased429,022May 15, 2026
VANGUARD FIDUCIARY TRUST CONew Position193,436May 8, 2026
NORTHERN TRUST CORPIncreased183,181May 14, 2026
MORGAN STANLEYReduced157,621May 15, 2026
DIVISADERO STREET CAPITAL MANAGEMENT, LPUnchanged100,000May 15, 2026
GOLDMAN SACHS GROUP INCReduced99,845May 15, 2026
AQR CAPITAL MANAGEMENT LLCReduced94,361May 15, 2026
NEWEDGE ADVISORS, LLCIncreased86,885Jun 3, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position82,301May 8, 2026
GOLDMAN SACHS GROUP INCReduced80,613Mar 25, 2026
UBS GROUP AGReduced62,454May 5, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 24, 2026